Search research articles
Contact Us
Filters
Showing results (81-90 of 131) with videos related to
Page
of 14
Sort By:
Wiener Klinische Wochenschrift
|
May 13, 1988
Shift in phenotype of acute T-lymphocytic leukemia to eosinophilic leukemia: a case report
P P Preis, C C Zielinski, W Linkesch, et al.
Cancer Research
|
August 1, 1993
Transforming growth factor-beta 1 interferes with the proliferation-inducing activity of stem cell factor in myelogenous leukemia blasts through functional down-regulation of the c-kit proto-oncogene product
S de Vos, M A Brach, Y Asano, et al.
Cancer Investigation
|
January 1, 1993
Combination treatment of acute myeloblastic leukemia with rhGM-CSF and standard induction chemotherapy
P Valent, C Sillaber, K Geissler, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 1, 1990
Prognostic significance of surface marker expression on blasts of patients with de novo acute myeloblastic leukemia
I Schwarzinger, P Valent, U Köller, et al.
British Journal of Haematology
|
March 1, 1985
Cell lineage heterogeneity in blast crisis of chronic myeloid leukaemia
P Bettelheim, D Lutz, O Majdic, et al.
The Journal of Clinical Investigation
|
June 1, 1985
Deficiency of the autologous mixed lymphocyte reaction in patients with classic hemophilia treated with commercial factor VIII concentrate. Correlation with T cell subset distribution, antibodies to lymphadenopathy-associated or human T lymphotropic virus, and analysis of the cellular basis of the deficiency
J S Smolen, P Bettelheim, U Köller, et al.
Annals of Hematology
|
February 1, 1992
Simultaneous occurrence of t(14;18) and t(8;22) common acute lymphoblastic leukemia
C Marosi, P Bettelheim, A Chott, et al.
Annals of Hematology
|
May 1, 1991
Coincidence of acquired factor-X deficiency and disseminated intravascular coagulation in patients with acute nonlymphoblastic leukemia
I Pabinger, P Bettelheim, R Dudczak, et al.
Thrombosis and Haemostasis
|
December 7, 1992
Recurrent, isolated factor X deficiency in myeloma: repeated normalization of factor X levels after cytostatic chemotherapy followed by late treatment failure associated with the development of systemic amyloidosis
I Schwarzinger, M Stain-Kos, P Bettelheim, et al.
Blut
|
November 1, 1984
Efficacy of the M-2 protocol in previously untreated patients with advanced multiple myeloma
H Gössinger, P Bettelheim, E Neumann, et al.
Page
of 14
Search research articles
Search
Showing results (81-90 of 131) with videos related to
Sort By:
Page
of 14
Wiener Klinische Wochenschrift
|
May 13, 1988
Shift in phenotype of acute T-lymphocytic leukemia to eosinophilic leukemia: a case report
P P Preis, C C Zielinski, W Linkesch, et al.
Cancer Research
|
August 1, 1993
Transforming growth factor-beta 1 interferes with the proliferation-inducing activity of stem cell factor in myelogenous leukemia blasts through functional down-regulation of the c-kit proto-oncogene product
S de Vos, M A Brach, Y Asano, et al.
Cancer Investigation
|
January 1, 1993
Combination treatment of acute myeloblastic leukemia with rhGM-CSF and standard induction chemotherapy
P Valent, C Sillaber, K Geissler, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 1, 1990
Prognostic significance of surface marker expression on blasts of patients with de novo acute myeloblastic leukemia
I Schwarzinger, P Valent, U Köller, et al.
British Journal of Haematology
|
March 1, 1985
Cell lineage heterogeneity in blast crisis of chronic myeloid leukaemia
P Bettelheim, D Lutz, O Majdic, et al.
The Journal of Clinical Investigation
|
June 1, 1985
Deficiency of the autologous mixed lymphocyte reaction in patients with classic hemophilia treated with commercial factor VIII concentrate. Correlation with T cell subset distribution, antibodies to lymphadenopathy-associated or human T lymphotropic virus, and analysis of the cellular basis of the deficiency
J S Smolen, P Bettelheim, U Köller, et al.
Annals of Hematology
|
February 1, 1992
Simultaneous occurrence of t(14;18) and t(8;22) common acute lymphoblastic leukemia
C Marosi, P Bettelheim, A Chott, et al.
Annals of Hematology
|
May 1, 1991
Coincidence of acquired factor-X deficiency and disseminated intravascular coagulation in patients with acute nonlymphoblastic leukemia
I Pabinger, P Bettelheim, R Dudczak, et al.
Thrombosis and Haemostasis
|
December 7, 1992
Recurrent, isolated factor X deficiency in myeloma: repeated normalization of factor X levels after cytostatic chemotherapy followed by late treatment failure associated with the development of systemic amyloidosis
I Schwarzinger, M Stain-Kos, P Bettelheim, et al.
Blut
|
November 1, 1984
Efficacy of the M-2 protocol in previously untreated patients with advanced multiple myeloma
H Gössinger, P Bettelheim, E Neumann, et al.
Page
of 14